Phraxis, Inc. is an early stage medical device company founded to develop novel treatment solutions for patients who need vascular access to enable hemodialysis. Phraxis, Inc.’s first product for commercialization, the InterGraft, will be a percutaneously delivered arterio-venous shunt that provides a unique, non-surgical approach for patients who need vascular access.